BIRC5 and cancer: It has been shown that LINC00857 enhances BIRC5-dependent radio-sensitivity of cancer cells (Han et al., 2020), regulates apoptosis and glycolysis (Wang et al., 2020b), and is identified as one of the prognostic markers for the early stage lung adenocarcinoma (Mu et al., 2021).